# Solventum Corp (SOLV)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/solventum-corp/ JSON: https://steadybase.io/company/solventum-corp.json Checked Nov 10, 2026. Latest filing read: Nov 5, 2026.

## Company

- Legal name: Solventum Corp
- Ticker: SOLV (NYSE)
- SEC CIK: 0001964738
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: Eagan, MN
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: solventum.com
- Investor relations: https://investors.solventum.com/
- LinkedIn: https://www.linkedin.com/company/solventumhealth
- Next earnings date: Feb 5, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $8.3B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.html
- Operating income: $2.2B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.html
- Net income: $1.6B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.html
- SG&A: $3.1B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.html
- Employees: 10,000 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm
- Shares outstanding: 169,739,335 as of Oct 31, 2026 (10-Q filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000056/0001964738-26-000056-index.html
- Auditor: Pricewaterhousecoopers LLP, Minneapolis, Minnesota, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm

## Business

Solventum Corporation ("Solventum," "we," "our," "us," or the "Company"), is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs. We constantly seek to enable the improvement of standards of care and move healthcare forward with innovation powered by insights, clinical intelligence, technology, and manufacturing expertise.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $8.3B | $2.2B | $1.6B | $3.1B |
| Dec 31, 2024 | $8.3B | $1.0B | $479.0M | $2.8B |
| Dec 31, 2023 | $8.2B | $1.7B | $1.3B | $2.3B |
| Dec 31, 2022 | $8.1B | $1.7B | $1.3B | $2.2B |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/solventum-corp.json

## Officers and directors

- Bryan C. Hanson, Chief Executive Officer. Source: Form 4 filed Sep 3, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000152434926000008/0001524349-26-000008-index.htm
- Wayde D. McMillan, Chief Financial Officer. Source: Form 4 filed May 15, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000176864826000005/0001768648-26-000005-index.htm
- Wayde McMillan, Executive Vice President and Chief Financial Officer (Mr. McMillan is the Principal Financial Officer and has been duly authorized to sign on behalf of the Regi. LinkedIn: https://linkedin.com/in/wayde-mcmillan-9b233b33. Source: 10-K filed Feb 27, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm
- Neil Craig Zieselman, SVP, Controller & CAO. Source: Form 4 filed Aug 18, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000161127526000006/0001611275-26-000006-index.htm
- Neil Zieselman, Senior Vice President, Controller and Chief Accounting Officer. LinkedIn: https://linkedin.com/in/neil-zieselman. Source: 8-K filed Jul 20, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000196473826000038/solv-20260716.htm
- Amy Landucci, Chief Information Officer. LinkedIn: https://linkedin.com/in/amylanducci. Source: Form 4 filed May 15, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000201581326000007/0002015813-26-000007-index.htm
- Marcela A. Kirberger, Chief Legal Affairs Officer. Source: Form 4 filed May 15, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000186888126000005/0001868881-26-000005-index.htm
- Mary T. Wilcox, Chief Accounting Officer. Source: Form 4 filed May 15, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000201606126000005/0002016061-26-000005-index.htm
- Paul S. Harrington, Chief Supply Chain Officer. Source: Form 4 filed May 15, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000201593226000005/0002015932-26-000005-index.htm
- Tammy L. Gomez, Chief Human Resources Officer. Source: Form 4 filed May 15, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000193748126000007/0001937481-26-000007-index.htm
- Heather Knight, Chief Commercial Officer. LinkedIn: https://linkedin.com/in/heather-knight-2620084. Source: Form 4 filed Mar 9, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000196752826000002/0001967528-26-000002-index.htm
- Marcela Kirberger, Chief Corporate & Legal Affairs Officer. Source: 10-K filed Feb 27, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm
- Mary Wilcox, Senior Vice President, Corporate Controller and Chief Accounting Officer (Principal Accounting Officer). Source: 10-K filed Feb 27, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm
- Paul Harrington, Chief Supply Chain Officer. LinkedIn: https://linkedin.com/in/paul-harrington-42aab517. Source: 10-K filed Feb 27, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm
- Tammy Gomez, Chief Human Resources Officer. LinkedIn: https://linkedin.com/in/tammy-gomez-793ab260. Source: 10-K filed Feb 27, 2026, https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm

## Recent 8-K events

- Nov 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000055/solv-20261105.htm
- Aug 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000045/solv-20260805.htm
- Aug 5, 2026: Item 7.01, Regulation FD disclosure; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000043/solv-20260805.htm
- Jul 20, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000038/solv-20260716.htm
- Jun 5, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000036/solv-20260602.htm
- May 27, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000031/solv-20260521.htm
- May 20, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000027/solv-20260515.htm
- May 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000022/solv-20260505.htm
- Mar 24, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000013/solv-20260320.htm
- Feb 26, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000005/solv-20260226.htm

## Insider trades (Form 4)

- Mar 10, 2026: Amy McBride Wendell (Director) bought 1,475 shares, about $100,344. Source: https://www.sec.gov/Archives/edgar/data/1964738/000140056826000002/0001400568-26-000002-index.htm

## What management said

- "Solventum delivered third quarter results ahead of our expectations, with every segment contributing, even as we completed our largest ERP cutover; we expect to be near the top end of our full-year organic sales growth range, and are raising our full-year adjusted earnings per share outlook" Bryan Hanson, chief executive officer of Solventum (8-K filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000055/q32026-8kerexx991.htm

## Latest filings

- 8-K filed Aug 5, 2026: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000045/solv-20260805.htm
- 10-K filed Feb 27, 2026: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm
- 10-Q filed Aug 5, 2026: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000047/solv-20260630.htm
- DEF 14A filed Mar 27, 2026: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000017/solv-20260327.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/